2023 annual financial data
OnKure Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -36,934,000 USD and net income was -35,311,000 USD.
Operating cash flow was -34,546,000 USD.
Get free OnKure Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -36,934,000 USD
- Net income
- -35,311,000 USD
- Operating cash flow
- -34,546,000 USD